These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 14962483
1. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Kupatt C, Hinkel R, Horstkotte J, Deiss M, von Brühl ML, Bilzer M, Boekstegers P. Cardiovasc Res; 2004 Feb 15; 61(3):530-7. PubMed ID: 14962483 [Abstract] [Full Text] [Related]
2. Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Kupatt C, Wichels R, Deiss M, Molnar A, Lebherz C, Raake P, von Degenfeld G, Hahnel D, Boekstegers P. Gene Ther; 2002 Apr 15; 9(8):518-26. PubMed ID: 11948377 [Abstract] [Full Text] [Related]
3. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Kupatt C, Hinkel R, Lamparter M, von Brühl ML, Pohl T, Horstkotte J, Beck H, Müller S, Delker S, Gildehaus FJ, Büning H, Hatzopoulos AK, Boekstegers P. Circulation; 2005 Aug 30; 112(9 Suppl):I117-22. PubMed ID: 16159802 [Abstract] [Full Text] [Related]
4. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species. Fantinelli JC, Cingolani HE, Mosca SM. Cardiovasc Pathol; 2006 Aug 30; 15(4):179-84. PubMed ID: 16844548 [Abstract] [Full Text] [Related]
5. Multiple treatment approach to limit cardiac ischemia-reperfusion injury. Davies JE, Digerness SB, Killingsworth CR, Zaragoza C, Katholi CR, Justice RK, Goldberg SP, Holman WL. Ann Thorac Surg; 2005 Oct 30; 80(4):1408-16. PubMed ID: 16181879 [Abstract] [Full Text] [Related]
6. Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection. Ten Hove M, Van Echteld CJ. Cardiovasc Res; 2004 Feb 15; 61(3):522-9. PubMed ID: 14962482 [Abstract] [Full Text] [Related]
7. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model. Muraki S, Morris CD, Budde JM, Zhao ZQ, Guyton RA, Vinten-Johansen J. J Thorac Cardiovasc Surg; 2003 Jan 15; 125(1):155-64. PubMed ID: 12538999 [Abstract] [Full Text] [Related]
16. Effects of acute and chronic treatment with the sodium hydrogen exchanger 1 (NHE-1) inhibitor cariporide on myocardial infarct mass in rabbits with hypercholesterolaemia. Jung O, Albus U, Lang HJ, Busch AE, Linz W. Basic Clin Pharmacol Toxicol; 2004 Jul 15; 95(1):24-30. PubMed ID: 15245573 [Abstract] [Full Text] [Related]
17. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size. Kristo G, Yoshimura Y, Ferraris SP, Jahania SA, Mentzer RM, Lasley RD. J Am Coll Surg; 2004 Oct 15; 199(4):586-94. PubMed ID: 15454144 [Abstract] [Full Text] [Related]
20. Cardioprotection of cariporide evaluated by plasma myoglobin and troponin I in myocardial infarction in pigs. Létienne R, Bel L, Bessac AM, Denais D, Degryse AD, John GW, Le Grand B. Fundam Clin Pharmacol; 2006 Apr 15; 20(2):105-13. PubMed ID: 16573710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]